RecruitingNCT03146936
Swiss Primary Sclerosing Cholangitis Cohort Study
Sponsor
Fondazione Epatocentro Ticino
Enrollment
120 participants
Start Date
Feb 28, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.
Eligibility
Inclusion Criteria2
- Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
- patients living in Switzerland
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03146936
Related Trials
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
NCT068659241 location
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
NCT0629799316 locations
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
NCT047539961 location
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
NCT066991217 locations
Primary Sclerosing Cholangitis in Children
NCT0418113812 locations